Related Experiment Videos

Intraoperative testing of the valtrac biofragmentable anastomotic ring

G Celoria¹, E Falco, A Nardini

¹Department of Surgery II, Ospedale Sant'Andrea, La Spezia, Italy.

The British Journal of Surgery

|May 1, 1993

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Safety and efficacy of encorafenib-cetuximab combination in BRAF V600E -mutated metastatic colorectal cancer: real-world evidence from the CONFIDENCE Spanish multicenter study.

ESMO real world data and digital oncology·2026

Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer.

Gynecologic oncology·2023

Turgor loss point and vulnerability to xylem embolism predict species-specific risk of drought-induced decline of urban trees.

Plant biology (Stuttgart, Germany)·2021

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).

BMC cancer·2019

Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study.

European journal of cancer (Oxford, England : 1990)·2018

See all related articles